My intention has never been to give the management a hard time. I have consistently raised concerns with the hope that ASIC will guide the company’s leadership to fulfil their legal and ethical obligations to shareholders.
The petition I submitted — and the issues it raises — are not acts of hostility. They are constructive calls for greater transparency, accountability, and improved governance. This initiative is intended as a note of encouragement, urging management to act in the best interests of all shareholders.
By reaching out to ASIC, I hope to encourage other shareholders to do the same — not to dismantle or discredit the company, but to help ensure that Biotron is managed transparently, responsibly, and with a focus on real outcomes.
We all want the company to succeed. But true success must be driven by tangible results, open communication, and a fair alignment between executive compensation and actual performance.
I also encourage others to approach regulators with their own concerns, as they see fit. Many community members and posters — including FM, GY, Lux, and others — have contributed valuable insights from different perspectives. My petition incorporates a combination of views from both holders and non-holders, and it can serve as a baseline for others seeking to engage with regulators and help guide Biotron’s management in the right direction — for the benefit of all stakeholders.
- Forums
- ASX - By Stock
- Helping Biotron to Do Better and Deliver Tangible Results: Shareholders Call for ASIC Action and Regulatory Scrutiny
BIT
biotron limited
Add to My Watchlist
0.00%
!
0.2¢

My intention has never been to give the management a hard time....
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.654M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $9.297K | 4.648M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
58 | 36124677 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 18314543 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
58 | 36124677 | 0.002 |
32 | 65031001 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 18314543 | 26 |
0.004 | 12820969 | 17 |
0.005 | 6684000 | 5 |
0.006 | 1200000 | 2 |
0.007 | 1084188 | 2 |
Last trade - 14.18pm 26/06/2025 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online